Sales results Q2 2017
-
Financial
VEXIM: Continued Growth and Adoption of the SpineJack® in Q2 2017
July 11, 2017 TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM), a medical device company specializing in the minimally…
Read More »